phenylbutazone has been researched along with Myelodysplastic Syndromes in 1 studies
Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.
Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohyashiki, K | 1 |
| Ohyashiki, JH | 1 |
| Raza, A | 1 |
| Preisler, HD | 1 |
| Sandberg, AA | 1 |
1 other study available for phenylbutazone and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Phenylbutazone-induced myelodysplastic syndrome with Philadelphia translocation.
Topics: Aged; Humans; Karyotyping; Male; Myelodysplastic Syndromes; Phenylbutazone; Philadelphia Chromosome; | 1987 |